The case against Martha Stewart surrounded her sale of shares in ImClone Systems Inc., Had she acted responsibly?

The case against Martha Stewart surrounded her sale of 3,928 shares in ImClone Systems Inc., and whether she lied to investigators and her companys investors to the highest degree it. On Dec. 27, 2001, Stewart cashed out her ImClone stake at an bonnie price of $58.43, collecting about $229,500. After the market unopen the following day, the Food and Drug Administration announced its refusal to refreshen ImClones application for Erbitux, a promising cancer drug. The next avocation day, Dec. 31, ImClones shares opened at $45.39 per share. That difference in price would hasten cost Stewart about $51,200 if she sold first thing that morning.

Had she acted responsibly? The obvious answer is no. But I bear anyone to ignore the possibility that they could lose a large few of money in a short time. Her actions after sound the news that she could lose thousands of dollars were a matter of self preservation. For those that states its in all about the money; I ask, why then does a billionaire continue to buy low and sell high. Its clear theyve reached a point of saturation a few million dollars ago. For around its the thrill of the hunt not the kill that keeps them motivated; theyve sufficient severed heads mounted within their mansions. Compared to the recent actions of others CEOs Kenneth Lay of Enron and L.



Dennis Kozlowski of Tyco, Martha Stewart told what amounted to a little white lie - that aside, as a leader of any boldness one is held to a higher standard. Its against that measuring stick that leads me to mean that she acted irresponsibly.

Martha Stewart, born in 1941 as Martha Kostyra, grew up in Nutley, unsanded Jersey in a working-class family with six children. At an early age her mother taught her the basics of cooking,

If you want to get a full essay, order it on our website: Orderessay



If you want to get a full essay, wisit our page: write my essay .